According to a new report by RNCOS, “Global Genetic Testing Market Analysis”, the genetic testing market has witnessed a rapid growth over the past few years mainly backed by personalization of medical treatment. The market has reached an estimated mark of US$ 1.7 Billion in 2011 and is expected to exhibit splendid performance in the coming future also. This growth is also likely to propel growth of the other segments like next-generation sequencing and biomarker discovery.
During the study, our analysts have found that due to lax regulation, the number of companies offering DTC genetic tests has increased at a rapid pace in recent years. Developed countries including the US, the UK, and Canada have a leading edge in DTC segment compared to the others. In 2010, the intervention of FDA into DTC genetic testing market was a crucial development that is likely to impact the way DTC industry is operating and seeking to deliver its services to consumers.
While compiling the report, our team made an effort towards covering an in-depth analysis of the global genetic testing market that provides a quantitative and qualitative analysis of the overall market size along with key industry drivers. The report, which is spread over 70 pages, provides extensive information and rational analysis on the emerging sectors and recent researches along with regulatory challenges, which are collectively impacting the industry’s outlook globally. It also provides brief information of the key industry players and their recent activities.
The report covers all the key aspects of the global genetic testing market that uses effective forecasting methods and techniques in order to present a realistic future outlook. It also provides insights on country-level market scenario and disease-wise analysis, and also provides a brief overview of the industrial development. Overall, the report has effectively used all the necessary statistics and information on the global genetic testing market that will prove decisive for intending clients.
|
